Skip to content
HomeLatest newsOur heritage133 years of innovative Credo-driven decisions that have made Johnson & Johnson the healthcare leader it is today
FINAL LEDE- 132 Years of Innovative Credo-Driven Decisions That Have Made Johnson & Johnson the Healthcare Leader It Is Today- Lede Collage

133 years of innovative Credo-driven decisions that have made Johnson & Johnson the healthcare leader it is today

To help mark 75 years since the company went public, we’re retracing some of the pivotal acquisitions, inventions and decisions that have guided the company for more than a century.

Share Article
share to
Back in 1943, General Robert Wood Johnson famously crafted Our Credo—the Johnson & Johnson mission statement that guides company thinking to this day, from big-picture deals and acquisitions down to the most basic day-to-day decisions.

The ethics it outlines, though, date back nearly 60 years earlier. That’s when Johnson & Johnson was founded to help address an unmet medical need for safer, sterile surgical products that could help save the lives of more patients—and make it easier for doctors to do so.

This blend of business savvy and concern for the health of humanity would go on to characterize the company throughout its 133-year history.

As we start a new year—and celebrate 75 years since the company went public—we take a look at just some of the ways the company has exemplified Credo-based thinking, from 1886 to the present, in this fun timeline.
  • Inset- 132 Years Credo-Driven Decisions- First Check
    The first Johnson & Johnson check, written on March 26, 1886

    Forming a Credo-Minded Company

    Robert Wood Johnson founded Johnson & Johnson with his brothers James and Edward with the goal of manufacturing the first mass-produced antiseptic surgical dressings and sutures. Johnson’s drive to advance healthcare innovation and his diverse and inclusive hiring practices—eight of his initial 14 employees were women—set the tone for the people-first values the company would espouse in the decades to come.
  • Inset- 132 Years Credo-Driven Decisions- Maternity PAckets

    Creating Supplies to Help Protect Mom and Baby

    The company’s iconic baby business kicked off with Maternity Kits, first-of-their-kind parcels filled with antiseptic soap, sterile medical supplies and other products to help make at-home childbirth safer and more hygienic than it was at the time.
  • Inset- 132 Years Credo-Driven Decisions- Spanish American War J&J Employee
    A Johnson & Johnson employee (left) with a fellow Spanish-American War soldier

    Supporting Employees Serving in the Military

    During the Spanish-American War, the company held the jobs—and paid the salaries—of all employees who served.

    This legacy of military support lives on today: Service members at the company receive full pay for up to 24 consecutive months while activated in the National Guard or Reserve, as well as paid time off to help reacclimate to work life upon their return.
  • Inset- 132 Years Credo-Driven Decisions- Galveston Hurricane
    Getty Images

    Caring for People in Times of Crisis

    Johnson & Johnson’s disaster relief efforts began after a deadly hurricane made landfall in Galveston, Texas, in 1900 (shown at right), with a donation of medical supplies used by local relief workers to treat wounded survivors.

    This company commitment to helping those impacted by natural disasters and humanitarian crises continues to this day. In 1980, the Worldwide Contributions group—now known as Global Community Impact—was officially formed to help assist the world’s most vulnerable people through partnerships with organizations like the United Nations Foundation and UNICEF.
  • Inset- 132 Years Credo-Driven Decisions- Chicopee Village
    Chicopee Village, a healthy residence Johnson & Johnson provided to local mill workers

    Providing Groundbreaking Employee Benefits

    When the company opened the first modern American textile mill in Chicopee, Georgia, it also offered health and wellness perks to employees living there that were virtually unheard of at the time, like on-site exercise facilities and neighborhoods designed for walking.
  • Inset- 132 Years Credo-Driven Decisions- Ortho-Gynol

    Launching Prescription Family Planning

    The company continued its dedication to the health and welfare of women when it founded the Ortho research labs and produced the first prescription spermicidal contraceptive jelly, Ortho-Gynol®.
  • General Robert Wood Johnson

    Drafting the Credo

    General Robert Wood Johnson (shown at right), the third president of the company, crafted the first iteration of Our Credo—the document that publicly spelled out the values that guided Johnson & Johnson in making any decision relating to either the business, the well-being of its employees or the people it serves. Although the Credo has evolved over the years, its spirit and focus has remained unchanged.
  • Inset- 132 Years Credo-Driven Decisions- IPO Stock

    Taking the Company Public

    A year after Our Credo was introduced, Johnson & Johnson became a publicly traded company, bringing to life the document’s stated fiscal responsibility to its stockholders. The initial stock price was $37.50 a share—the equivalent of 375 loaves of bread that year.
  • Inset- 132 Years Credo-Driven Decisions- Ethicon building
    The original Ethicon, Inc. headquarters

    Growing the Suture Business

    The company formed Ethicon, Inc., allowing Johnson & Johnson to take its groundbreaking invention of sterile surgical sutures into the modern age and increasing its value to shareholders.
  • Inset- 132 Years Credo-Driven Innovation- Paul Janssen
    Image courtesy of Johnson & Johnson Archives

    Innovating Pharmaceutical Treatments

    Johnson & Johnson’s acquisition of Janssen Pharmaceuticals, founded by Dr. Paul Janssen (shown at right), has since led to the development of groundbreaking treatments for cancer, diabetes, HIV and many other diseases that impact people around the globe. Janssen’s overriding goal: invest in innovation that helps address unmet medical needs, enabling people to live longer, healthier lives.
  • Headshot of James Burke
    © Brownie Harris Productions 1981

    Trailblazing With Employee Health Benefits

    Then-CEO James Burke (shown at right) launched a groundbreaking wellness program called Live for Life® to help his employees become some of the healthiest in the world through access to behavior modification tools and education on topics like nutrition and stress management. It was an effective way to fulfill the Credo’s stated responsibility to employees—and lives on through the company’s current goal to engage 100,000 or more employees toward a personal best in health and well-being by 2020.
  • Inset- 132 Years Credo-Driven Decisions- Sustainability

    Declaring the Company’s Commitment to the Environment

    New verbiage was added to Our Credo outlining Johnson & Johnson’s responsibility to “protecting the environment and natural resources,” in line with a growing global awareness of needing to preserve the health of the planet.
  • Inset- 132 Years Credo-Driven Decisions- Father parental leave

    Evolving the Credo to Include Fathers

    In recognition of the fact that parents who use Johnson & Johnson products comprise both men and women, the word “fathers” was added alongside “mothers” in the very first line of the Credo, making clear the company’s responsibility to all members of the family.

    Today, Johnson & Johnson dads around the world are eligible to take a minimum of eight weeks paid leave for the birth or adoption of a child.
  • Inset- 132 Years of Credo-Driven Innovation- Mountain lake environment

    Setting Citizenship and Sustainability Goals

    Johnson & Johnson started publicly setting environmental performance goals 26 years ago, with a top priority being pollution prevention.

    Today, the company’s objectives have expanded to become the Health for Humanity goals, which also aim to prevent the global spread of disease, and much more.
  • Inset- 132 Years Credo-Driven Innovation- 1995 Neutrogena Amber Bar ad

    Growing the Company’s Role in Innovative Skincare

    Johnson & Johnson was long known as an expert on babies and their delicate skin when it expanded its work in skincare by acquiring Neutrogena® in 1994, helping turn the brand into the household name it is today. The acquisitions of Clean & Clear®, RoC® and Aveeno® in the same decade further cemented the company as a major player in skincare science.
  • Inset- 132 Years Credo-Driven Decisions- Orthopedic elderly couple

    Expanding Expertise in Orthopedic Care

    The acquisition of DePuy, followed by the acquisition of Synthes in 2012, led to the formation of DePuy Synthes, a medical device company that offers cutting-edge solutions for patients in need of help with joint replacements, spinal care and more.
  • TEST Inset- 132 Years of Innovative Credo-Driven Decisions That Have Made Johnson & Johnson the Healthcare Leader It Is Today- Replacement Listerine

    Acquiring Iconic OTC Brands

    Johnson & Johnson acquired Pfizer’s consumer healthcare business and, along with it, such classic household brands as Listerine® and Neosporin® that help improve families’ personal health.
  • Inset- 132 Years Credo-Driven Decisions- JLABS San Diego exterior

    Launching a Healthcare Incubator to Help Support Innovative Start-Ups

    The first Johnson & Johnson Innovation, JLABS health sciences incubator debuted in San Diego (shown at right). Today, there are 13 sites around the globe that help carry out the Credo’s mandate to “experiment with new ideas” and ensure “innovative programs [are] developed.”
  • Inset- 132 Years Credo-Driven Decisions- Save the Children
    Image courtesy of Rebecca Zilenziger/Save the Children

    Helping Save the Children

    Save the Children was named Johnson & Johnson’s first-ever enterprisewide global partner to help support a company mission to improve the survival and healthy development of children under age 5, especially newborns. Together, the organizations have worked on everything from training healthcare workers in neonatal resuscitation to helping with earthquake and hurricane relief efforts.

    The partnership was renewed in 2018, the same year Johnson & Johnson launched a new tool called Wisdom by Kids designed to support children’s health around the world. Through the end of 2019, the platform will benefit Save the Children in celebration of the organization’s 100th anniversary.
  • Inset- 132 Years Credo-Driven Decisions- working mother

    Enhancing Parental Leave for Employees

    Johnson & Johnson announced that it was offering all new parents in the United States eight weeks of additional paid leave; these benefits were expanded and made available globally over the next couple of years, leading to numerous accolades, including consistent placement on Working Mother’s 100 Best Companies list.
  • Inset- 132 Years Credo-Driven Decisions- Actelion

    Adding an Important New Treatment Focus

    The acquisition of Actelion allowed the company to add a sixth area of focus to its pharmaceutical portfolio: pulmonary hypertension. Janssen’s work to help address unmet patient needs is focused on cancer, infectious diseases, cardiovascular and metabolic diseases, autoimmune and other inflammatory diseases and diseases of the brain.
  • Inset- 132 Years Credo-Driven Decisions- Janssen Transparency 2

    Providing Transparency Around Pharmaceutical Pricing and Practices

    The first Janssen U.S. Transparency Report was released to help shed light on company decisions around pricing and other business practices.
  • Inset- 132 Years Credo-Driven Decisions- Baby Products Transparency

    Unveiling a 100% Fragrance Ingredient Transparency Disclosure

    Johnson’s® made news by disclosing 100% of the ingredients in its baby products, including those found in fragrances. It further fulfilled a commitment the company first made to help safeguard the health of babies back in 1894.

Bringing Our Credo to life

Learn more about how this legendary document has helped guide decisions that have improved lives around the world.

More from Johnson & Johnson

By the numbers: Understanding dry eye disease

For National Dry Eye Awareness Month, learn about the causes of this common condition and how Johnson & Johnson is helping to find treatment options.

What to know about We All Belong: 2023 DEI Impact Review

The annual report details how Johnson & Johnson is harnessing the power of diversity, equity and inclusion to provide better care around the world.
You are now leaving The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.